Personalized treatments for blood and bone cancer
September 30, 2021
University of Cincinnati researchers have joined a nationwide clinical trial exploring the effectiveness of personalized treatments for patients with acute myelogenous leukemia (AML), a cancer of the blood and bone marrow.